HOME >> BIOLOGY >> NEWS
Key gene in orchestrating embryo development also fine tunes organization of the retina

the horizontal cells to stop multiplying so there will be only a limited number of these neurons," Dyer said. "So this study also helps to explain the big mystery of how horizontal cells succeed in making that critical ratio."

This latest discovery adds to the growing list of roles Prox1 plays. "Prox1 has been a central gene in every organ we've studied so far in the developing embryo," Oliver said. "We've previously discovered that Prox1 is critical to the normal development of the liver, the lens of the eye, and the entire lymphatic system, which is a critical part of the immune system."

The ongoing work at St. Jude has demonstrated that during embryo development, Prox1 plays at least three critical roles. It controls the proliferation of cells, prompts cells to migrate from their original positions in the embryo to the location where they will help form a tissue or organ and makes those cells become a very specialized cell type so they perform a specific task in that organ or tissue. Other authors of this report include Constance L. Cepko (Harvard University, Boston) and Frederick J. Livesey (Harvard University and Wellcome/CRC Institute of Cancer and Developmental Biology, University of Cambridge, UK).


'"/>

Contact: Bonnie Cameron
bonnie.cameron@stjude.org
901-495-4815
St. Jude Children's Research Hospital
1-May-2003


Page: 1 2

Related biology news :

1. Sequential signals choreograph embryonic tubule formation
2. Therapeutic cloning no longer a dream, says scientist who produced first cloned embryonic stem cell
3. Conflicting views on embryonic and adult stem cells complicate research in stem cell therapeutics
4. MIT technology jump-starts human embryonic stem cell work
5. Genetic testing of embryos to pick savior sibling OK with most Americans
6. Researchers model embryo implantation and tumour metastasis in fruit flies
7. New human embryonic stem-cell lines to be made available to researchers
8. Most clones doomed from the start, according to Temple University embryologist
9. Jefferson researchers uncover biochemical clues to how cells migrate in embryos
10. Human embryonic stem cells may promise medical advances
11. Destructive wizardry of Ozz-E3 ligase appears key to building skeletal muscles in embryos and adults

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
(Date:3/29/2017)... -- higi, the health IT company that operates the largest ... , today announced a Series B investment from BlueCross ... new investment and acquisition accelerates higi,s strategy to create ... health activities through the collection and workflow integration of ... and secures data today on behalf of over 36 ...
(Date:3/24/2017)... Research and Markets has announced the addition of the ... Industry Forecast to 2025" report to their offering. ... The Global Biometric Vehicle Access ... 15.1% over the next decade to reach approximately $1,580 million by ... and forecasts for all the given segments on global as well ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... ... its endogenous context, enabling overexpression experiments and avoiding the use of exogenous expression ... guides is transformative for performing systematic gain-of-function studies. , This complement to ...
(Date:10/11/2017)... the Netherlands and LAGUNA HILLS, Calif. ... The Institute of Cancer Research, London ... use MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients ... trial known as MUK nine . The University of ... trial, which is partly funded by Myeloma UK, and ICR ...
(Date:10/10/2017)... CA (PRWEB) , ... October ... ... a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today ... of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration ...
(Date:10/10/2017)... ... October 10, 2017 , ... USDM Life ... for the life sciences and healthcare industries, announces a presentation by Subbu Viswanathan ... The presentation, “Automating GxP Validation for Agile Cloud Platforms,” will present a revolutionary ...
Breaking Biology Technology:
Cached News: